Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
MINT1526A is a monoclonal antibody against integrin alpha 5 beta 1 that blocks interaction with extracellular matrix thus potentially leads to tumor cell death (PMID: 29905898).
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Bevacizumab + MINT1526A||Bevacizumab MINT1526A||3||0|